Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
60 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
mylife Diabetes Care Belgium from Anderlecht, company number BE0681676705, closed financial year 2025 with a result of € 39,613 after tax. For that financial year mylife Diabetes Care Belgium recorded a gross margin of € 328,988 and equity of € 351,384. Compared with financial year 2024, the result moved from € 6,325 to € 39,613. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 5, 2025.
€ 351,384
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 39,613
▲ € 33,288 vs 2024
Profit after tax over the fiscal year.
€ 299,821
▲ 264% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 51,384.
People and assets in 2025
2
▲ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 259,667
▲ 10% vs 2024
€ 129,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,969
▼ 37% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 250,422
▲ 100% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 142,782
▲ 41% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 188,500 | € 216,287 | € 257,548 | € 328,988 | ▲ 28% |
| Profit after taxes | € -1,243 | € 3,352 | € 6,325 | € 39,613 | ▲ € 33,288 |
| Equity | € 302,095 | € 305,447 | € 311,772 | € 351,384 | ▲ 13% |
| Total debts | € 179,456 | € 186,966 | € 398,617 | € 475,763 | ▲ 19% |
| Cash | € 28,271 | € 32,621 | € 82,422 | € 299,821 | ▲ 264% |
| Retained profit | € 2,095 | € 5,447 | € 11,772 | € 51,384 | ▲ € 39,613 |
| Bank debt | € 100,000 | € 100,000 | € 100,000 | € 0 | ▼ 100% |
| Balance sheet total | € 481,550 | € 492,413 | € 710,389 | € 827,147 | ▲ 16% |
| Employees (FTE) | 2 | 1.7 | 1.7 | 2 | ▲ 0.3 |
Key figures of mylife Diabetes Care Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to mylife Diabetes Care Belgium?
What happened at mylife Diabetes Care Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 39,613 (▲ € 33,288 vs 2024). filed late Source: NBB ↗
- Johan Lundstörm became a director. NBB
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,243 loss in 2022 to € 39,613 profit in 2025.
Paid € 47,244 in corporate taxes since 2022.
Best year ever: 2025, with € 39,613 profit.
On average € 164,500 of value added per employee in 2025.
A new publication or filing at mylife Diabetes Care Belgium? We notify you, reason included.
Follow mylife Diabetes Care BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind mylife Diabetes Care Belgium is Johan Lundstörm.
Directors
According to the 2025 annual accounts
Johan Lundstörm
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Researchdreef 12
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 60 companies are registered at this address.
All companies at this address →Vereniging van Frabrikanten en Invoerders van wetenschappelijke Medische en Controleapparaten
€ 678,657 revenue · 2025
CYRILLUS BENELUX
€ 1.9 million revenue · 2025
BATICOOL
€ 336,834 gross margin · 2024
EEBIC
€ 669,567 gross margin · 2025
TRIANGLE SOLUTIONS RH
€ 21.1 million revenue · 2024
+55 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
TTM, DE
Domain
Domain
ypsomed.be
Registered
2003-07-22
Website info
Features
Security
Network
Details
- Company number
- 0681.676.705
- VAT number
- BE 0681.676.705
- Registered office
- Researchdreef 12, 1070 Anderlecht
- Names & denominations
- mylife Diabetes Care Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 September 2017
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- ypsomed.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren